Please login to the form below
Sanofi gets green light for Lantus follow-up Toujeo
Once-daily basal insulin gains FDA approval for diabetes
Actavis gets FDA nod for new antibiotic
Avycaz is the fifth antibiotic to gain US approval in recent months
BMS buys immunotherapy specialist Flexus in $1.2bn deal
And signs new cancer research partnership with Rigel
Shire boosts orphan drug pipeline with Meritage Pharma deal
Firm will also acquire global rights to Meritage’s phase III OBS compound
Remicade biosimilars hit European market
Hospira and Mundipharma begin marketing their version of the blockbuster drug
Gilead's Sovaldi wins NICE approval but faces access delay
The Institute also recommends Janssen's hepatitis C drug Olysio
Takeda grows in Turkey with Neutec subsidiary acquisition
Will acquire Toplam Kalite for up to 300m Turkish lira
US lawmaker pushes for drug price transparency
If passed a new Bill would demand pharma show how product price tags are worked out
Merck rode out rival to sign $450m deal with NGM
Part of a five-year alliance on metabolic disorders and cancer
Future gazing: What does 2015 hold for NICE?
Undermined by the CDF, the Institute is set to face a number of challenges this year
-
England's Cancer Drugs Fund: Fixing a broken systemFollowing the culling of 16 medicines from the Fund PME looks at how to improve market access for new oncology products
-
The problem with pillsConventional solid dosage forms have failed to keep pace with modern consumers’ evolving demands
-
Good NICE news for Pfizer, but Dendreon drug rejected Kidney cancer drug Inlyta backed but prostate cancer treatment Provenge is not
-
Rosetta merges with Razorfish Healthware to launch new agencyMerger will create Razorfish Health
-
UK doctors call on NHS to use Avastin for wet AMDControversial practice of using the drug off-label could save the health service £102m
-
Novartis gets OK for panobinostat in myelomaFirst HDAC to receive positive FDA review
-
Lilly delays filing of Lantus rival on safety concernsConcerns over changes in liver fat detected in phase III trials
-
Google-backed genetic testing kit gains FDA approval 23andMe’s DNA test can alert consumers to their risks of certain diseases
-
French pharma growth restricted by genericsNew analysis finds country’s market value will grow only modestly in the coming years
Latest appointments
-
UCB CEO elected to the Ministerial Industry Strategy GroupJean-Christophe Tellier assumed the role of CEO on January 1
-
Werner Baumann to replace Brandicourt at BayerWill assume the role of chairman after the former boss jumped ship to Sanofi
-
Kymab names Anne Hyland as chief financial officerHyland joins from BBI Diagnostics
-
Everyday Health appoints PHCG presidentMichael du Toit to take up same position
-
W Communications strengthens management teamSunil Ramkali and Elisabet Ek join as partners
Featured jobs
- Director – Client Engagement – Brand Team - Reading, Berkshire...
-
Senior level salary + comprehensive benefits
- AM or Senior Account Manager – Digital – Healthcare Advertising ...
-
EXTENSIVE PACKAGE AVAILABLE
- FREELANCE!! Account Manager / Senior Account Manager – TOP 5 Hea...
-
VERY COMPETITIVE DAY RATE
- Associate Project Director – Meetings Management - Reading, Berk...
-
Competitive + excellent benefits
- Senior Medical Writer
-
Competitive Salary Offered
DGH Recruitment
- Account Manager & Senior Account Manager – Medical Communica...
-
£33000 - £48000 + BONUS + BENEFITS
- Healthcare PR Account Manager, Internal Communications
-
c£30-35,000 according to skills and experience
- Assistant Editor – Clinical Pharmacy: The Pharmaceutical Journal...
-
Competitive Salary Offered
- Account Executive and Senior Account Executive NEEDED for FUN &...
-
Bonus + Benefits
Subscribe to our email news alerts
- Dementia research alliance to fast-track new Alzheimer's drugs
- Bayer HealthCare launches online cardiovascular tool
- Half a million cancer patients in EU use targeted drugs
- NICE issues fresh rejection for Celgene’s cancer drug Imnovid
- AstraZeneca employs Wolfram tech for liver health research
- Early win for Pfizer as Remicade biosimilar launches in West Europe
- Indigenus Announces Global Executive Mariana Sanchez as new Director
- Indigenus Announces the Winners of the 2013 indiGENIUS Awards
- Indigenus Expands Coverage With Two New Associate Agencies
- Future gazing: What does 2015 hold for NICE?
- Sanofi gets green light for Lantus follow-up Toujeo
- Eisai adds online patient stories to Belviq marketing
PMHub
DDB Remedy
Sixty years ago Bill Bernbach, Ned Doyle and Maxwell Dane gave the advertising industry a wake-up call.They introduced a new...
Latest intelligence
- E-detailing content wow factor in 2015
- Many companies are reporting that the iPad novelty has worn off and healthcare professionals are demanding more than just another animation presented on a mobile device. So what exactly are...
- Free White Paper: Multichannel Marketing for Pharma
- Transitioning successfully to multichannel marketing takes careful planning. When done right, pharma can deliver a personalised experience for each customer. Download our white paper to learn how...
- How to confirm customer understanding in e-detailing
- Done right, e-detailing takes away the guesswork in your marketing....
Quick links
